News Trump’s pick for FDA chief causes concern Jim O’Neill could be in line to take charge of the agency.
News FDA and EMA to work more closely on paediatric drug regulati... FDA and EMA hope to streamline development of paediatric plans.
Views & Analysis Digital Health Round-up – Apple's cautious approach to healt... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Pfizer looks to confirm US licence for breast cancer pill Pfizer has filed late stage data with FDA.
News Novartis drug gets fast US review in AML Midostaurin also under review in rare disease systemic mastocytosis
News Sanofi abandons phase 3 trial of neurology drug riliprubart Sanofi's neurology pipeline has had a hole blown in it after a phase 3 trial of riliprubart in rare disease CIDP was stopped for futility.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
